SK
Shubham Kumar Jaiswal
About Shubham Kumar Jaiswal
Data last updated:
Shubham Kumar Jaiswal has 4 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Raythe Oncare Pharmulations Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Raythe Oncare Pharmulations Private Limited at ₹40.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 20 Nov 2021 | 2021 | ₹40.1 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shubham Kumar Jaiswal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shubham Kumar Jaiswal
Shubham Kumar Jaiswal has 4 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Raythe Oncare Pharmulations Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Raythe Oncare Pharmulations Private Limited at ₹40.1 Lakh (FY 2025).
Shubham Kumar Jaiswal is associated with 1 company as Additional Director, including Raythe Oncare Pharmulations Private Limited (₹40.1 Lakh).
Shubham Kumar Jaiswal has expertise in General Business.
Shubham Kumar Jaiswal has 4 years in corporate governance.
By reported revenue, the largest current company of Shubham Kumar Jaiswal is Raythe Oncare Pharmulations Private Limited, with revenue of ₹40.1 Lakh (FY 2025).
Shubham Kumar Jaiswal currently holds positions at 1 company: Raythe Oncare Pharmulations Private Limited (₹40.1 Lakh).